Axonics, Inc. ( AXNX) - Key Metrics
Stock symbol AXNX is outdated, potentially delisted? Maybe it is available on other exchange?
AXNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $2.27 | $0 | $0.02 | -$0.05 |
| 2024Q2 | $2.24 | $0.13 | $0.33 | $0.31 |
| 2024Q1 | $1.79 | -$0.38 | -$0.18 | -$0.24 |
| 2023Q4 | $2.22 | $0.13 | $0.11 | $0.09 |
| 2023Q3 | $1.86 | $0.08 | $0.25 | $0.22 |
AXNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -42330.12 |
| 2024Q2 | ? | 124.94 |
| 2024Q1 | ? | -46.11 |
| 2023Q4 | ? | 116.91 |
| 2023Q3 | ? | 178.90 |
AXNX
Price: $70.98
52 week price:
Earnings Per Share: -0.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 679900
Market Capitalization: 3.6 billion